We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+12.08%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.3B
AUM Growth
+$1.78B
Cap. Flow
-$127M
Cap. Flow %
-0.66%
Top 10 Hldgs %
22.48%
Holding
1,354
New
98
Increased
525
Reduced
537
Closed
58

Top Sells

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$47.8M
2
PG icon
Procter & Gamble
PG
+$38.9M
3
EA icon
Electronic Arts
EA
+$37.8M
4
KO icon
Coca-Cola
KO
+$31.9M
5
FISV
Fiserv Inc
FISV
+$27.8M

Sector Composition

Rank Sector Weight
1 Technology 23.3%
2 Healthcare 11.77%
3 Consumer Discretionary 9.87%
4 Financials 9.74%
5 Industrials 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ON icon
51
ON Semiconductor
ON
$33.8B
$86.5M 0.45%
1,035,907
-4,820
-0.5% -$379K
PH icon
52
Parker-Hannifin
PH
$125B
$86.5M 0.45%
187,756
-7,377
-4% -$3.07M
VEA icon
53
Vanguard FTSE Developed Markets ETF
VEA
$226B
$85.8M 0.45%
1,792,052
+7,342
+0.4% +$329K
COST icon
54
Costco
COST
$415B
$84.5M 0.44%
128,001
+722
+0.6% +$428K
BRK.B icon
55
Berkshire Hathaway Class B
BRK.B
$1.07T
$82.9M 0.43%
232,450
-2,683
-1% -$942K
PNC icon
56
PNC Financial Services
PNC
$100B
$79.9M 0.41%
515,921
-4,270
-0.8% -$553K
ITW icon
57
Illinois Tool Works
ITW
$81.4B
$78.3M 0.41%
299,113
+3,533
+1% +$847K
IVV icon
58
iShares Core S&P 500 ETF
IVV
$869B
$78M 0.4%
163,334
+7,405
+5% +$3.31M
MRK icon
59
Merck
MRK
$324B
$77.5M 0.4%
711,290
-239,929
-25% -$24.9M
ELV icon
60
Elevance Health
ELV
$81.9B
$75.3M 0.39%
159,704
+16,475
+12% +$7.62M
EFA icon
61
iShares MSCI EAFE ETF
EFA
$76.4B
$74.5M 0.39%
988,370
-4,176
-0.4% -$295K
PGR icon
62
Progressive
PGR
$124B
$73.6M 0.38%
462,385
-52,446
-10% -$8.21M
FTNT icon
63
Fortinet
FTNT
$112B
$73.4M 0.38%
1,254,043
+121,781
+11% +$6.73M
ADP icon
64
Automatic Data Processing
ADP
$100B
$73M 0.38%
313,365
-38,844
-11% -$9.05M
REGN icon
65
Regeneron Pharmaceuticals
REGN
$68.8B
$72.8M 0.38%
82,845
-1,913
-2% -$1.58M
BMY icon
66
Bristol-Myers Squibb
BMY
$127B
$72.3M 0.37%
1,408,188
+164,182
+13% +$8.62M
VRTX icon
67
Vertex Pharmaceuticals
VRTX
$121B
$70.8M 0.37%
174,096
-20,297
-10% -$7.5M
VUG icon
68
Vanguard Growth ETF
VUG
$216B
$70.3M 0.36%
1,356,378
+77,418
+6% +$3.74M
AME icon
69
Ametek
AME
$55.5B
$70.1M 0.36%
425,024
-28,311
-6% -$4.32M
PYPL icon
70
PayPal
PYPL
$49.5B
$69.2M 0.36%
1,126,767
+388,840
+53% +$22.3M
INTC icon
71
Intel
INTC
$466B
$68.5M 0.36%
1,363,630
-19,259
-1% -$782K
SCHW
72
Charles Schwab
SCHW
$177B
$68.5M 0.36%
995,193
+233,106
+31% +$13.5M
LH icon
73
Labcorp
LH
$24.3B
$68.3M 0.35%
300,710
-643
-0.2% -$135K
KO icon
74
Coca-Cola
KO
$354B
$67.7M 0.35%
1,149,127
-560,787
-33% -$31.9M
BLK icon
75
Blackrock
BLK
$164B
$65.8M 0.34%
81,020
-1,091
-1% -$762K

Similar funds

Glenmede Trust's Q4 2023 Portfolio in Review

As of Q4 2023, Glenmede Trust held 1,354 positions worth $19.3B, up 10% from $17.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Glenmede Trust's Q4 2023 filing shows 98 new, 525 increased, 537 reduced and 58 closed positions. Its largest new stake was Lamar Advertising Co: 133,106 shares worth $14.1M. The largest sale was Lowe's Companies, an estimated $47.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Glenmede Trust's largest Q4 2023 buy was Lamar Advertising Co: 133,106 shares worth $14.1M.
  • Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $86.6M increase.
  • Glenmede Trust's biggest Q4 2023 reduction was Lowe's Companies, cutting an estimated $47.8M.
  • Glenmede Trust fully exited Hostess Brands, Inc. Class A Common Stock in Q4 2023, selling an estimated $22.6M.
  • Glenmede Trust's ten largest holdings make up 22% of its $19.3B portfolio in Q4 2023.
  • Glenmede Trust opened 98 new positions and closed 58 in Q4 2023.
  • Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $19.3B.

Based on Glenmede Trust's 13F filing for Q4 2023, filed 13 Feb 2024.